7Y4G
sit-bound btDPP4
Summary for 7Y4G
Entry DOI | 10.2210/pdb7y4g/pdb |
Related | 7Y4F 8HAY |
Descriptor | btDPP4, (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-A MINE (3 entities in total) |
Functional Keywords | gut microbiota, hydrolase, hydrolase-inhibitor complex, hydrolase/inhibitor |
Biological source | Bacteroides thetaiotaomicron |
Total number of polymer chains | 3 |
Total formula weight | 247222.90 |
Authors | |
Primary citation | Wang, K.,Zhang, Z.,Hang, J.,Liu, J.,Guo, F.,Ding, Y.,Li, M.,Nie, Q.,Lin, J.,Zhuo, Y.,Sun, L.,Luo, X.,Zhong, Q.,Ye, C.,Yun, C.,Zhang, Y.,Wang, J.,Bao, R.,Pang, Y.,Wang, G.,Gonzalez, F.J.,Lei, X.,Qiao, J.,Jiang, C. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Science, 381:eadd5787-eadd5787, 2023 Cited by PubMed Abstract: A mechanistic understanding of how microbial proteins affect the host could yield deeper insights into gut microbiota-host cross-talk. We developed an enzyme activity-screening platform to investigate how gut microbiota-derived enzymes might influence host physiology. We discovered that dipeptidyl peptidase 4 (DPP4) is expressed by specific bacterial taxa of the microbiota. Microbial DPP4 was able to decrease the active glucagon like peptide-1 (GLP-1) and disrupt glucose metabolism in mice with a leaky gut. Furthermore, the current drugs targeting human DPP4, including sitagliptin, had little effect on microbial DPP4. Using high-throughput screening, we identified daurisoline-d4 (Dau-d4) as a selective microbial DPP4 inhibitor that improves glucose tolerance in diabetic mice. PubMed: 37535747DOI: 10.1126/science.add5787 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.97 Å) |
Structure validation
Download full validation report